Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Secura Bio brings in $145mm in first cash/debt round

Executive Summary

Secura Bio Inc. closed the initial tranche of what appears to be its Series A funding round, which included a $55mm equity investment by company executives and funds managed by Athyrium Capital, in addition to a $50mm debt financing provided by Athyrium. A second $40mm closing to the debt portion of the round remains available.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register